Four-Year Study of Intermittent Cyclic Etidronate Treatment of Postmenopausal Osteoporosis: Three Years of Blinded Therapy Followed by One Year of Open Therapy

    loading  Checking for direct PDF access through Ovid

Excerpt

Related Topics

    loading  Loading Related Articles